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The serine-threonine kinase mTOR signals through two multiprotein complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (1) (2) , and is a focal point in cell signaling integrating and responding to extracellular stimuli such as nutrients, stress, hormones or mitogens (1, 3) . mTORC1, unlike mTORC2, is sensitive to the acute treatment of the inhibitor rapamycin (2) . mTORC1 is best characterized for its ability to control the translation initiation of a subset of mRNAs via the phosphorylation and activation of the p70 ribosomal S6 kinase (S6K), and the phosphorylation of the eukaryotic translation initiation factor-4E binding protein (4E-BP) (1, (3) (4) .
In the central nervous system, long-lasting forms of synaptic plasticity and memory depend on new protein synthesis (4) (5) , specifically at dendrites (6) where mTORC1 and its downstream effectors S6K and 4E-BP are localized (7) (8) . The mTORC1-mediated local protein translation is critical for stabilizing plastic changes occurring at synapses (9) (10) . In addition, the mTORC1 pathway controls soma and dendritic morphology (11) , long-term potentiation (LTP) and depression (LTD) (4, 12) .
Finally, the mTORC1 signaling pathway has been shown to contribute to memory formation, consolidation and reconsolidation (4, 13) , as well as memory deficits (14) .
Drug and alcohol addiction is a disorder that shares striking molecular similarities with the neural mechanisms underlying learning and memory (15) , particularly in the mesocorticolimbic circuit where plasticity induced by drugs of abuse is well documented (15) (16) (17) . Addiction is a chronically relapsing psychiatric disease characterized by compulsion to seek and consume drugs, loss of control and emergence of a negative emotional state when access to drug is withdrawn (17) . Despite its massive health and 4 4 socioeconomic impact on the world population (18) (19) , molecular targets and pharmacotherapies for the treatment of drug and alcohol addiction are still limited.
Since mTORC1 plays a major role in neural plasticity, we hypothesized that this complex contributes to neuroadaptations within the mesolimbic system that result in excessive drug intake. We therefore tested the contribution of mTORC1 to alcohol consumption using rodent models of alcohol-drinking behaviors. First, we examined whether acute administration of alcohol alters the mTORC1-mediated signaling pathway in the NAc, a brain region within the mesolimbic system that is a critical component of the circuitry underlying reward and addiction (16, 20) . To do so, mice were systemically (intraperitoneally, i.p.) administered with a non-hypnotic dose of alcohol (2.5 g/kg), and the phosphorylation levels of the mTORC1 substrates, S6K and 4E-BP, were measured in the NAc 30 min after treatment. We found that acute in vivo exposure of mice to alcohol significantly increased the phosphorylation level of both proteins (Fig. 1A) indicating that alcohol exposure triggers the activation of the mTORC1 signaling pathway in the NAc.
Next, we assessed whether the mTORC1 pathway was activated in the NAc in rodent models of excessive drinking of alcohol. Recurring alcohol consumption and withdrawal periods trigger seeking and excessive drinking-behaviors (19, 21) , and a similar paradigm was used in mice and rats resulting in voluntary alcohol consumption that generated blood alcohol concentrations which correspond to human binge-drinking as defined by the National Institute on Alcohol Abuse and Alcoholism (22) (23) . Mice and rats were therefore trained to drink large quantities of alcohol (23), and activation of the mTORC1 signaling pathway in the NAc was determined. We found that binge-drinking of alcohol results in the activation of the mTORC1-mediated signaling cascade as 5 5 reflected by a higher phosphorylation-state of 4E-BP in the NAc of mice ( fig. S1 ), and rats (Fig. 1B) , as well as the phosphorylation of S6K in rats (Fig. 1B) . Interestingly, the phosphorylation levels of 4E-BP and S6K proteins in the rat NAc were also enhanced after 24 hrs of alcohol withdrawal (Fig. 1C) , suggesting a long-lasting activation of the mTORC1 signaling pathway following repeated exposure to alcohol. We therefore hypothesized that activation of mTORC1 signaling within the NAc is necessary for the maintenance of neuroadaptations contributing to excessive alcohol intake.
To test this possibility, we used the mTORC1 inhibitor rapamycin, an FDAapproved drug used for the prevention of host-rejection of organ transplants (24).
Rapamycin was administered to binge-drinking mice 3 hrs before the beginning of an alcohol-intake session ( fig. S2 ). We found that systemic administration of rapamycin dose-dependently reduced excessive alcohol drinking ( Fig. 2A and figs . S3A-C) without affecting water intake ( Fig. 2B and fig. S3D ). Acute administration of a high dose (40 mg/kg) of rapamycin does not alter locomotor activity in mice (13), and we observed that rapamycin did not affect mice motor coordination in the absence or presence of alcohol ( fig. S4 ). Thus, it is unlikely that the reduction in alcohol consumption induced by rapamycin was due to a nonspecific effect of the drug such as general decrease in fluid intake or an alteration in locomotor activity. Next, we tested for the contribution of mTORC1 activity within the mesolimbic system to excessive voluntary alcohol intake in rats ( fig. S5 ). We found that intra-NAc infusion of rapamycin 3 hrs before the beginning of the session significantly decreased alcohol (Fig. 3A) but not water (Fig. 3B ) intake over a period of 24-hr access. Notably, we also observed that inhibiting mTORC1 in the NAc was effective in reducing both binge drinking occurring during the first 30 min of 6 6 the session (Fig. 3C) , as well as alcohol intake during the rest of the drinking period (i.e. 30 min-24 hrs) ( fig. S6 ). These data show that in the NAc, mTORC1 is implicated not only in the first bout of excessive alcohol intake but also in the sustained consumption of alcohol.
To gain insight into the behavioral processes underlying the decrease in alcohol intake by rapamycin, we examined the effect of systemically administered rapamycin on the motivation of rats to consume alcohol. For this purpose, rats with a history of excessive alcohol consumption were trained to self-administer alcohol in an operant procedure on a fixed-ratio 3 schedule in which 3 lever-presses result in the delivery of 0.1ml of a 20% alcohol solution (25). Consistent with our previous results, systemic rapamycin treatment significantly reduced operant responding for alcohol (Fig. 4A ), which was accompanied by a large decrease (more than 50%) in the amount of alcohol consumed by rats during the 30-min session (Fig. 4B) . Because mTORC1 plays a key role in learning and memory (4), the reduction in operant self-administration in response to rapamycin could be a consequence of deficits in memory processes associated with lever pressing. However, rapamycin-treated rats were still able to discriminate between the lever delivering alcohol and the inactive lever suggesting an absence of such memory deficits (Fig. 4A) . Moreover, the effect of rapamycin on alcohol self-administration cannot be attributed to a nonspecific alteration in locomotion since acute administration of rapamycin to rats did not affect their locomotor activity in an open-field ( fig. S7 ).
Importantly, we observed that rapamycin reduced the high rate of lever presses occurring at the beginning of the self-administration session (Fig. 4C) , suggesting that rapamycin decreased the motivation to seek alcohol. To test this possibility, instrumental 7 7 performance was analyzed during extinction where alcohol was not delivered upon leverpressing. As shown in Fig. 4D , rapamycin administration decreased alcohol-seeking in rats as reflected by a reduction of the number of presses on the alcohol lever during an extinction session. Finally, to determine if the effect of rapamycin is specific to alcohol or could be generalized to other reinforcing substances, we examined the ability of rapamycin to modulate the self-administration of sucrose, a non-drug reinforcer. We observed that systemic rapamycin administration did not affect lever-press responding for sucrose (Fig. 4E ). This result further confirms that the decrease in alcohol selfadministration induced by rapamycin was not due to a general locomotor or memory deficit. It also indicates that the effect of rapamycin on operant self-administration is selective for alcohol and does not reflect a general attenuation of motivation to obtain a reward. Taken together, our data show that in rats with a history of excessive alcohol consumption, rapamycin selectively decreases alcohol intake by reducing their motivation to specifically seek alcohol.
Overall, the present work shows that mTORC1 positively regulates alcoholseeking and excessive alcohol consumption. The molecular mechanism by which mTORC1 contributes to neuroadaptations that underlie alcohol-drinking and -seeking behaviors remains to be determined. Nevertheless, we found that both mTORC1 substrates S6K and 4E-BP are phosphorylated after 24 hrs of alcohol deprivation in the NAc of rats with a history of high level of alcohol intake. Since both of these proteins are part of the mTORC1-mediated translation machinery (1, 3) , the kinase is likely to regulate alcohol intake, at least in part, via the translation of proteins whose expression is 8 8 necessary for the maintenance of mechanisms underlying alcohol drinking behaviors in the mesolimbic system. In summary, we present data to suggest that alcohol exposure induces a longlasting activation of the mTORC1 signaling pathway in the NAc that contributes to mechanisms underlying excessive alcohol drinking. Our results further document that the FDA-approved drug rapamycin decreases excessive alcohol intake as well as the motivation to seek alcohol in pre-clinical rodent models of alcohol abuse. Moreover, this effect of rapamycin is specific for alcohol and does not reflect a non-selective inhibition of the reward and motivational system, which is a critical point from a therapeutic perspective (26). Importantly, we found that rapamycin attenuates "binge-like" alcohol drinking behavior that is likely to result from a decrease in the motivation to seek alcohol.
This last finding is of particular interest because binge-drinking is an increasingly prevalent problem during adolescence and young adulthood and is a strong predictor of future alcohol-related problems (27-28). Our findings are also particularly relevant for the treatment of alcoholism where the pattern of drug consumption is often characterized by successive cycles of daily episodes of binge drinking and withdrawal (21) . In addition, lapse and relapse to alcohol drinking, which result in excessive alcohol consumption, are fundamental problems in alcoholism treatment. Our data therefore put forward the possibility that targeting the mTORC1 signaling cascade as an innovative and valuable strategy for the treatment of alcohol use and abuse disorders.
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MATERIALS AND METHODS
Materials
The following antibodies were purchased form Cell Signaling Technology: Phospho-S6K Thr389 (#9234), Phospho-4E-BP Thr37/46 (#2855), total S6K (#2708), total 4E-BP2
(#2845, 4E-BP2 is the main 4E-BP isoform in the brain (1-2) ). Secondary anti-rabbit Rapamycin (# R-5000) was purchased from LC-laboratories.
Animals
Male C57BL/6J mice were obtained from Jackson Laboratories (9 to 15 weeks old at the start of each experiment) and male Long-Evans rats (300-350 g at the beginning of the experiments) were purchased from Harlan. Mice and rats were individually housed and maintained in a temperature and humidity-controlled room under a 12 hr light: dark cycle (lights on at 07.00 am) with food and water available ad libitum, unless stated otherwise. DMSO and 5% DMSO in PBS for i.p. injection and intra-NAc infusion respectively.
Systemic administration of alcohol in mice
Mice were habituated to the i.p. administration procedure by being injected daily with saline (0.9 % sodium chloride, Hospira) for 3 days. One day later, mice were i.p. injected with alcohol (2.5g/kg, 20% (vol/vol)) or saline. Mice were killed by cervical dislocation 30 min later and their brains were rapidly removed and placed on an ice-cold platform.
The NAc were collected for western-blot analysis.
Western-blot analysis
After removal, the NAc was immediately homogenized in a RadioImmuno Precipitation 
Intermittent-limited-access 20% alcohol drinking paradigm in mice
Mice were acclimated on a reverse dark cycle for 1week (lights off from 10:00 am to 10:00 pm). Mice were individually housed and were allowed continuous access to tap water. Body weights were recorded weekly throughout the study. After acclimatization, mice were given access to alcohol using a limited-intermittent access procedure. Mice were given a solution of 20% alcohol in water (vol/vol) for 4 hrs every other day, with access beginning at 12:00 pm. A water bottle was always available when alcohol was not given, except during the 4-hr access sessions. Bottles were weighed immediately before 5 and after the 4 hr-access period. The amount of alcohol consumed (g/kg of body weight/4 hrs) was calculated as the difference in volume from the beginning and the end of the limited-access session. Drinking volumes were corrected for spillage using bottles containing alcohol solution placed in an empty cage during the limited access session.
This paradigm leads to a high level of alcohol intake (5-9 g/kg/4 hrs) in a restricted period of time resulting in blood alcohol concentrations (BECs) higher than 80 mg% (see below).
Experiment 1: effect of rapamycin on alcohol drinking
After 3 weeks of alcohol consumption leading to a stable alcohol intake of 5-9 g/kg/4 hrs, mice were randomly separated into rapamycin or vehicle-treated groups. Mice were injected i.p. with vehicle or rapamycin (1, 5, 10 and 20 mg/kg) 3 hrs before the beginning of the alcohol-drinking session in a volume of 2 ml/kg ( fig. S2 ). Alcohol intake was monitored 4 hrs later as described above.
Experiment 2: effect of rapamycin on water drinking
After 2 weeks without access to alcohol, mice were randomly separated into rapamycin or vehicle-treated groups. Then, mice were injected i.p. with rapamycin (10 mg/kg) or vehicle 3 hrs before the beginning of the water-drinking session starting at 12:00 pm.
Water intake was measured 4 hrs later.
BEC measurements in mice
Trunk blood was collected in heparinized capillary tubes at the end of the 4-hr limitedaccess 20% alcohol drinking session. Serum was extracted with 3.4% trichloroacetic acid followed by a 5 min centrifugation at 420 g and assayed for alcohol content using the 6 NAD + -NADH enzyme spectrophotometric method (3) (4) . The BECs were determined using a standard calibration curve. An average value of 97 ± 9 mg% (21 ± 2 mM) was obtained (n=8).
Measure of the smotor coordination in mice using the rotarod test
Experiment 1: Effect of rapamycin treatment on motor coordination
Mice were first trained to remain on a rotarod (Accurotor Rotarod; AccuScan Instruments, Inc) rotating at 10 RPM for 180 sec. At the end of the training, animals were randomly divided in 2 groups and then injected i.p. with rapamycin (10 mg/kg) or vehicle. Three hrs later, mice were tested every 15 min for 90 min and latency to fall was recorded for each trial.
Experiment 2: Effect of rapamycin treatment on alcohol-induced ataxia
Mice were first trained to remain on a rotarod rotating at 10 RPM for 180 sec. The following day, animals were randomly divided in 2 groups and then injected i.p. with rapamycin (10 mg/kg) or vehicle. Three hours later, each mouse was first tested to ensure it could stay on the rotarod for 180 sec and then was injected i.p. with 1.5 g/kg of alcohol.
Each mouse was retested every 15 min for 120 min. The latency to fall from the rod in each trial was recorded.
Intermittent-access 20% alcohol two-bottle-choice drinking paradigm in rats
Intermittent-access of 20% alcohol was similar to the paradigm described previously (5). For western-blots analyses of rat NAc, rats experienced at least 3 months (38 sessions) of intermittent-access 20% alcohol two-bottle-choice drinking paradigm.
Surgery
Surgery procedures began after 19 sessions of the two-bottle-choice drinking paradigm as described above, when rats reached a stable baseline of alcohol consumption of 5-6 g/kg/24 hrs ( fig. S5 ). Stereotaxic surgeries were conducted under isoflurane anesthesia (Baxter Health Care Corporation). Rats were positioned in a stereotaxic frame (David Kopf Instruments) and bilateral guide cannulae (C235G-2.0, 26 ga, Plastics One) were aimed at the NAc at the following coordinates (1.6 mm posterior to bregma, 1 mm mediolateral, 5.9 mm ventral to the skull surface (7) . Cannulae were secured with stainless-steel screws and dental acrylic; stylets were inserted into the guide cannulae to 8 maintain injector site clear of debris. After 3 days of recovery, intermittent-access 20% alcohol procedure was resumed and microinfusions started when alcohol drinking returned to a stable baseline.
Intra-NAc infusion of rapamycin
Rats were microinjected with rapamycin (0.005, 0.5, 5 or 50 ng) or vehicle 3 hrs before the beginning of the 24-hr alcohol-drinking session. A total of 1 µl of rapamycin or vehicle was infused over 2 min into the NAc of gently restrained rats via injection cannulae extending 1 mm beyond the guide cannula tip. Injection cannulae were left in place for an additional 1 min. After infusion, stylets were replaced in the guide cannulae and the animal was put back in the home cage. Alcohol and water intake were calculated 30 min and 24 hrs after the beginning of the session.
All subjects received each rapamycin dose in a counterbalanced manner, with one microinjection per week. Two alcohol-drinking sessions without treatment were carried out between microinjections to allow alcohol intake to return to the baseline level.
Operant alcohol self-administration after a history of high voluntary alcohol consumption
The procedure was adapted from (8) . High levels of voluntary alcohol consumption were obtained in an intermittent-access 20% alcohol (vol/vol) two-bottle-choice drinking paradigm as described above. After achieving a stable baseline of consumption, rats were trained to self-administer a 20% alcohol solution in operant self-administration chambers (Med Associates). The chambers contain two levers: an active lever, for which presses 9 result in delivery of 0.1 ml of the alcohol solution, and an inactive lever, for which presses are counted but no programmed events occur. The levers are retractable and they extend into the chamber at the initiation of each session and retract at the end of the session. After 2 to 3 nights in the chambers to allow acquisition of a lever-press response for alcohol under a fixed ration 1 (FR1), operant sessions were conducted 5 days per week with the schedule requirement increased to FR3 and the length of session shortened from 60 to 30 min over the first 2 weeks.
Experiments started after 6 weeks of alcohol self-administration upon acquisition of a stable baseline of responding. Rats were injected i.p. 3 hrs before the beginning of the operant self-administration session with 10 mg/kg of rapamycin or vehicle. The study was performed twice with a "within subjects" design in which rats received both treatments in counterbalanced order, with a week without treatment between the experiments to allow the lever-press responding for alcohol to return to baseline. Three weeks after the end of this experiment, the same rats were used to test the effect of the rapamycin (10 mg/kg, 3 hrs before the session) on extinction of alcohol selfadministration. Animals were probed with a single extinction trial during which animals could press the lever for 30 min without receiving access to alcohol (active lever responding activated the pump on an FR3 schedule, but no alcohol was delivered). All subjects received rapamycin or the vehicle in a counterbalanced manner. The extinction trials were separated by 2 weeks of standard alcohol self-administration as described above allowing the lever-press responding for alcohol to return to baseline between treatments.
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Operant sucrose self-administration in rats
The operant sucrose self-administration procedure was performed as previously described (8) S8 ). Subjects with injection cannulae located in the NAc were included in the study.
Data analysis
Biochemical data were analyzed with an unpaired t-test. Rat two-bottle-choice and operant self-administration experiments were conducted in a within-subject design whereas mice limited-access drinking experiments were conducted in a between-subject 
